Women's Health Archive

Using hormone therapy, which involves taking estrogen and sometimes progesterone, doesn’t stop or slow the approach of menopause. The arrival of menopause is determined by women’s ovaries, not by the amount of these hormones in the body.

Studies show that women’s pain experiences are often minimized, dismissed, or undertreated by clinicians. Women and men perceive pain differently. Factors contributing to women’s undertreatment for pain include lack of objective pain measures, uncertain diagnoses, clinician bias, and how women are socialized. Women can ensure their pain is taken seriously by communicating closely with clinicians about expectations, stating they recognize their pain may not be 100% relieved, and doing their own research on possible reasons for pain.

A 2025 research review suggested that women with certain gynecological disorders, such as polycystic ovary syndrome, endometriosis, heavy periods, and irregular menstrual cycles, have higher risks of cardiovascular and cerebrovascular disease.

Women receive less information about perimenopause compared with the earlier milestones of puberty and pregnancy. Some women deal with an array of symptoms they don't connect to perimenopause and aren't aware that lifestyle changes can offset them. The menopause transition often involves weight gain from both shifting hormones and aging. Regular exercise and strength training can mitigate weight gain. Healthy eating habits and sounder sleep can also offset perimenopausal symptoms.

Women officially reach menopause a year after periods end. Any vaginal bleeding after menopause should be evaluated. Bleeding can come from vaginal dryness or atrophy, medication side effects, various infections, endometrial thickening, or cancer.

The FDA added a boxed warning in December 2024 to fezolinetant (Veozah), a nonhormonal drug that reduces hot flashes and night sweats in menopausal women. The drug may cause rare but serious liver injury.